Contract Research & Services
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
366
NCT01474564
Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Phase: N/A
Role: Collaborator
Start: Nov 30, 2011
Completion: Oct 31, 2019
NCT02555735
Exceptional Responders With Solid Tumor Cancer to Chemotherapy
Role: Lead Sponsor
Start: Oct 31, 2015
Completion: Aug 31, 2027
NCT03422510
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
Phase: Phase 2
Start: Apr 15, 2018
Completion: Jul 31, 2020
Loading map...